In 2026, the spotlight will be on a handful of therapeutic strategies that could change cancer care for patients by offering ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Many breast cancer drugs block estrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis. But most patients with advanced disease eventually ...

Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy ...

The team that steered a clinical-stage cancer drug to an acquisition by Eli Lilly is back at it again, unveiling a new venture supported by $177 million for a pipeline of precision medicines ...

Researchers at Nano Life Science Institute (WPI-NanoLSI) and the Cancer Research Institute at Kanazawa University have ...

A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...

The company joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer.

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told BioSpace, with both rare and chronic diseases headlining investor and R&D ...

CAMBRIDGE, England--(BUSINESS WIRE)--Crescendo Biologics Ltd (Crescendo), the developer of novel, targeted, T cell enhancing therapeutics, and Cancer Research UK, the world’s largest independent ...

This year, JPM 2026 took place again in San Francisco. Let’s look at predictions and trends forecast for 2026, according to ...